GAMMA Investing LLC grew its holdings in Genpact Limited (NYSE:G - Free Report) by 9,371.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 490,903 shares of the business services provider's stock after purchasing an additional 485,720 shares during the period. GAMMA Investing LLC owned about 0.28% of Genpact worth $24,732,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in G. Coppell Advisory Solutions LLC raised its stake in shares of Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after acquiring an additional 503 shares in the last quarter. SRH Advisors LLC purchased a new position in Genpact during the 4th quarter worth $26,000. Atlas Capital Advisors Inc. raised its position in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares in the last quarter. GeoWealth Management LLC grew its holdings in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after acquiring an additional 583 shares in the last quarter. Finally, Manchester Capital Management LLC purchased a new position in Genpact during the 4th quarter valued at about $38,000. 96.03% of the stock is currently owned by institutional investors.
Insider Transactions at Genpact
In other news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nicholas C. Gangestad bought 2,000 shares of Genpact stock in a transaction that occurred on Tuesday, May 13th. The stock was purchased at an average price of $43.97 per share, with a total value of $87,940.00. Following the purchase, the director now directly owns 2,000 shares in the company, valued at $87,940. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 3.07% of the company's stock.
Analyst Upgrades and Downgrades
G has been the subject of several research reports. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a research report on Friday. Robert W. Baird reduced their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Finally, Needham & Company LLC cut their price target on Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $50.71.
View Our Latest Research Report on Genpact
Genpact Stock Up 2.4%
NYSE:G traded up $0.99 during midday trading on Friday, reaching $43.09. 1,606,953 shares of the stock traded hands, compared to its average volume of 1,377,593. The stock has a market capitalization of $7.54 billion, a PE ratio of 15.17, a price-to-earnings-growth ratio of 1.84 and a beta of 0.94. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The business has a 50-day moving average of $45.98 and a two-hundred day moving average of $47.24.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The business had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. During the same period in the prior year, the firm posted $0.73 earnings per share. The business's quarterly revenue was up 7.4% on a year-over-year basis. On average, equities analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.58%. Genpact's dividend payout ratio is presently 23.21%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.